Skip to main content

Find Clinical Trials

Home
Conditions
Urologic Neoplasms

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

105 public trials 26 recruiting studies

Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Recruiting

Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue

NCT02379429

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +12 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Skin Conductance for Predicting Spinal Anesthesia-Induced Hypotension in Geriatric Urologic Oncology Patients

NCT07481851

Conditions: Aged, Cardiovascular Diseases, Female Urogenital Diseases, +11 more
Locations: Dr. Abdurrahman Yurtaslan Ankara Oncology Education and Research Hospital Clinic of Anesthesiology and Rea Ankara, Yenimahalle, Turkey (Türkiye)

View Trial Details

Recruiting

Web-Based Application for Monitoring Radiation Therapy Complications in Cancer Patients

NCT07416630

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +13 more
Locations: Institute of Oncology Ljubljana Ljubljana, Slovenia

View Trial Details

Recruiting

CD70-targeted immunoPET Imaging of Kidney Cancer

NCT06680089

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
Locations: Renji Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Carboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile Cancer

NCT06353906

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +14 more
Locations: UZ Leuven Leuven, Belgium

NKI-AVL Amsterdam, North Holland, Netherlands

View Trial Details

Recruiting

Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma

NCT06676527

Conditions: Adenocarcinoma, Antineoplastic Agents, Carcinoma, +15 more
Locations: Jinling Hospital Nanjing, Jiangsu, China

View Trial Details

Recruiting

A Study of BL-B01D1 in Patients With Multiple Solid Tumors, Including Locally Advanced or Metastatic Urinary System Tumors

NCT05785039

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +8 more
Locations: Fudan University ShangHai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy

NCT04442724

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
Locations: Cedars-Sinai Medical Center (CSMC) Los Angeles, California, United States

University of California Los Angeles Los Angeles, California, United States

Harvard School of Medicine/Massachusetts General Hospital (MGH) Boston, Massachusetts, United States

View Trial Details

Recruiting

VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapy

NCT05920343

Conditions: Cardiovascular Diseases, Embolism and Thrombosis, Female Urogenital Diseases, +12 more
Locations: Ottawa Hospital Research Institute Ottawa, Ontario, Canada

View Trial Details

Recruiting

Palliative Radiotherapy in Symptomatic Pelvic Soft Tissue Tumors

NCT06398314

Conditions: Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, +13 more
Locations: Helse Møre og Romsdal Ålesund, Norway

Haukeland universitetssykehus Bergen, Norway

Nordlandssykehuset Bodø Bodø, Norway

Vestre Viken HF Drammen, Norway

View Trial Details